EP Patent

EP0196769B1 — A novel transdermal pharmaceutical absorption dosage unit

Assigned to Rutgers State University of New Jersey · Expires 1992-07-08 · 34y expired

What this patent protects

A novel transdermal pharmaceutical polymer matrix dosage unit is provided which comprises a backing layer, an adjoining layer of a solid polymer matrix in which the pharmaceutical is microdispersed and a final biologically acceptable adhesive polymer layer which has dispersed the…

USPTO Abstract

A novel transdermal pharmaceutical polymer matrix dosage unit is provided which comprises a backing layer, an adjoining layer of a solid polymer matrix in which the pharmaceutical is microdispersed and a final biologically acceptable adhesive polymer layer which has dispersed therein a skin permeation enhancer.

Drugs covered by this patent

Patent Metadata

Patent number
EP0196769B1
Jurisdiction
EP
Classification
—
Expires
1992-07-08
Drug substance claim
No
Drug product claim
No
Assignee
Rutgers State University of New Jersey
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.